ZBH Zimmer Biomet Holdings, Inc. logo

ZBH Zimmer Biomet Holdings, Inc.

Healthcare
$85.50+0.22%ClosedMarket Cap: $16.54B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

25.69

PEG

P/B

1.13

P/S

1.97

EV/EBITDA

10.69

DCF Value

$483.36

FCF Yield

11.1%

Div Yield

1.1%

Margins & Returns

Gross Margin

70.0%

Operating Margin

15.6%

Net Margin

9.1%

ROE

5.8%

ROA

3.4%

ROIC

5.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$2.09B$238.1M$
Q4 null$2.24B$139.5M$
FY null$8.23B$705.2M$
Q3 null$2.00B$230.9M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$96.33

Target (Median)

$93.00

Target Range

$83.00 - $120.00

2 Strong Buy6 Buy17 Hold1 Sell1 Strong Sell
CitizensMarket Outperform
2026-04-29
StifelBuy
2026-04-29
Truist SecuritiesHold
2026-04-29
JP MorganNeutral
2026-04-29
CitigroupNeutral
2026-04-29

Trading Activity

Insider Trades

View All
Stellato Paul Aofficer: VP, Controller, CAO
SellTue May 05
Noor Jehanzebofficer: See remarks below.
SellFri Apr 03
Noor Jehanzebofficer: See remarks below.
SellFri Apr 03
Shapiro Louisdirector
SellThu Apr 02
Kurdikar Devdattdirector
SellThu Apr 02

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.47

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Peers